Valsartan + HCTZ

DRUG2 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

Hypertension

Phase 3

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

CompletedNCT00327587

NovartisHypertension

Start: 2006-05-31End: 2007-08-31Updated: 2011-11-08

Phase 4

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

CompletedNCT00698646

Novartis PharmaceuticalsHypertension

Start: 2008-04-30End: 2009-06-30Updated: 2011-04-19

Related Papers

Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.

2013-07-0113 citations